Testosterone and Kidney Function: What TRT Users Need to Know

Written by Adam Maggio | Medically reviewed by Dr. Mitchell Ross, MD, ABAARM

TRT is generally safe for kidneys, but it can indirectly affect markers like creatinine due to increased muscle mass. Monitoring is important, especially for those with pre-existing conditions.

Testosterone and Kidney Function: What TRT Users Need to Know

The relationship between Testosterone Replacement Therapy (TRT) and kidney function is a topic that warrants careful consideration for both patients and clinicians. While TRT is generally considered safe and effective for treating hypogonadism, understanding its potential impact on renal health is crucial for comprehensive patient management. Unlike the clear hepatotoxic risks associated with 17-alpha-alkylated oral steroids, the direct impact of modern TRT on kidney function is less straightforward and often misunderstood.

The kidneys play a vital role in filtering waste products from the blood, regulating blood pressure, and producing hormones like erythropoietin. Healthy kidney function is essential for overall well-being. Testosterone, being an anabolic hormone, can influence various physiological processes, including muscle mass, red blood cell production, and metabolic pathways, all of which can indirectly affect kidney health. However, direct nephrotoxicity (kidney damage) from therapeutic doses of testosterone, particularly with non-oral delivery methods, is not a commonly observed phenomenon.

Indirect Effects and Considerations

While direct damage is rare, several indirect factors related to TRT can influence kidney function:

• Increased Muscle Mass: Testosterone promotes muscle protein synthesis. An increase in muscle mass can lead to a slight elevation in serum creatinine levels, a common marker used to estimate glomerular filtration rate (eGFR). This elevation is often due to increased creatinine production from muscle metabolism, not necessarily a decline in kidney function. Clinicians should be aware of this physiological change and interpret creatinine levels in the context of increased muscle mass, potentially using cystatin C-based eGFR equations for a more accurate assessment of renal function in muscular individuals on TRT.
• Polycythemia: As discussed previously, TRT can stimulate red blood cell production, leading to erythrocytosis or polycythemia. Severely elevated hematocrit increases blood viscosity, which can theoretically reduce renal blood flow and place additional strain on the kidneys. Managing polycythemia through dose adjustments or therapeutic phlebotomy is therefore important for overall cardiovascular and renal health.
• Blood Pressure Regulation: Testosterone can influence blood pressure. While some studies suggest TRT may have a neutral or even beneficial effect on blood pressure in certain populations, others indicate a potential for slight increases. Uncontrolled hypertension is a major risk factor for chronic kidney disease (CKD). Therefore, diligent monitoring and management of blood pressure are essential for TRT users, especially those with pre-existing hypertension.
• Metabolic Syndrome and Diabetes: Hypogonadism is often associated with metabolic syndrome and type 2 diabetes, both of which are significant risk factors for CKD. TRT has been shown to improve insulin sensitivity, reduce visceral fat, and improve glycemic control in hypogonadal men. By ameliorating these metabolic risk factors, TRT may indirectly offer a protective effect on kidney health in this population.

Monitoring Kidney Function on TRT

Routine monitoring of kidney function is a standard practice for all individuals on TRT. Before initiating therapy, baseline serum creatinine, eGFR, and urinalysis should be obtained. During TRT, these parameters are typically re-evaluated at 3-6 months and then annually. For patients with pre-existing CKD, more frequent monitoring and careful consideration of TRT benefits versus risks are warranted.

It is important for healthcare providers to differentiate between a physiological rise in creatinine due to increased muscle mass and a true decline in kidney function. If there is a significant or progressive decline in eGFR, further investigation, including repeat testing, evaluation for other causes of kidney disease, and potentially a nephrology consultation, is necessary. Overall, when administered appropriately and monitored diligently, TRT is not typically detrimental to kidney health in men with normal renal function. However, a personalized approach, considering individual risk factors and comorbidities, is always recommended.